HIP1R and central nervous system cancer: Gliomas with HIP1R+ tumor cells greater than 23.6% were more likely to carry 1p19q codeletion, with an AUC of 70.6%, suggesting that the proportion of HIP1R+ tumor cells had good predictive power for 1p19q codeletion.